Artificial Intelligence
ReSync Bio, Sapio Sciences adopt Nvidia BioNeMo to supercharge AI drug discovery
Drug Discovery, Aortic Valve Insufficiency, Sapio, Sapio Sciences, Bio, NVIDIA ‘s, BioNeMo, microservices
Six Payer Trends Shaping Market Access in 2025
Market, trends qualifier, Access, Enrollment, 2025, payer, Shapes, payers, Artificial Intelligence
MeiraGTx and Hologen AI Form $430M Collaboration to Advance Parkinson’s Gene Therapy
gene therapy, Parkinson’s disease, artificial intelligence, clinical trials, biotechnology partnership
Insilico secures $110M in new funding for AI-designed pipeline
Clinical Trials, Aortic Valve Insufficiency
Lila Sciences Emerges with $200M to Build AI-Powered Scientific Superintelligence Platform
AI, scientific discovery, autonomous labs, Flagship Pioneering, seed funding
Freed Raises $30M to Transform Medical Documentation with AI-Powered Assistant
AI medical scribe, clinician burnout, administrative burden, healthcare technology, Series A funding
Oncology Market in 2025: Innovation, Growth, and Patient-Centric Care
Cancer immunotherapy, Targeted therapies , Precision medicine, AI in oncology, Combination treatments, Biosimilars, Clinical trial design, Personalized cancer care
The Perfect Storm: Why 2025 Will Be the Year of GxP AI in Pharma
GxP AI, pharmaceutical manufacturing, regulatory compliance, data-driven innovation, quality management, drug development
Amgen expands Indian footprint with $200M tech hub
Amgen, India, Technology, Site, Data Science, Aortic Valve Insufficiency, India ‘s
Incyte and Genesis Therapeutics Forge $620M AI-Driven Drug Discovery Partnership
Artificial intelligence, drug discovery, small molecule therapeutics, GEMS platform, oncology, immunology, strategic collaboration